Drug shortages are a complex and global phenomenon. When a drug cannot be delivered at the moment of patient demand, every stakeholder in the health care system is affected. The aim of this study was to investigate the characteristics, clinical impact, financial impact and management of drug shortages in European hospital pharmacies and identify opportunities for prevention and mitigation of dr...

P 2 c bjective: To examine current and future physical therapy (PT) job surplus/shortage rends across the United States. esign: Forecast models and grading methodology previously published for nursing were sed to evaluate individual state PT job shortages from 2008 to 2030. etting: Not applicable. articipants: Not applicable. ethods: The forecast model used to project PT job supply and demand a...

Second-line drugs (SLDs) are essential for treating multidrug-resistant and extensively drug-resistant tuberculosis (MDR TB* and XDR TB†). Drug shortages, in which supplies of all clinically interchangeable versions of a given Food and Drug Administration (FDA)-regulated drug become inadequate to meet actual or projected user demand, have been well-documented in many areas of medicine; for seve...

The recent IJHPR article by Schwartzberg and colleagues presents new data on the growing problem of prescription drug shortages. Resolving shortages typically involves many participants: government, industry, physicians and healthcare facilities. Israel has a strong record of informal collaboration that can fix drug shortages quickly. The success of Israel's informal collaborations, as well as ...

Shortages in medicine supply are usually associated with the now well-known representation of impoverished, underdeveloped countries suffering famine, episodes of vast epidemics, and accounts of immeasurable morbidity and mortality. However, it has become alarmingly clear that medicine shortages are now occurring in the most developed countries in the world and for several reasons. 1 Media head...

In this issue of Clinical Infectious Diseases, Strausbaugh et al. [1] present the results of 2 surveys of the Emerging Infections Network (EIN) performed in 1999 and 2000 regarding shortages of certain antibiotics. The EIN is a group of nearly 800 infectious disease physicians from all regions of the country, representing individual , group, and academic practices. They are supported by a contr...